Related Experiment Videos

Cryptococcosis at the University Hospital, Kuala Lumpur

S A Doi1, C T Tan, C K Liam

  • 1Clinical Training Unit, St George's University School of Medicine, Grenada.

Tropical Doctor
|March 3, 1998
PubMed

Insights

Combination therapy with amphotericin B and 5-fluorocytosine is effective for pulmonary and meningeal cryptococcosis. Early presentation and aggressive treatment of intracranial hypertension improve outcomes, while asymptomatic pulmonary cryptococcoma may be surgically resected.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Neurology

Background:

  • Cryptococcosis, particularly pulmonary and meningeal forms, is a significant cause of meningitis in immunocompetent adults in Malaysia.
  • Pulmonary cryptococcosis often presents with respiratory symptoms, while central nervous system (CNS) involvement is characterized by headaches and fever.

Purpose of the Study:

  • To review the experience with pulmonary and meningeal cryptococcosis cases.
  • To evaluate treatment strategies and outcomes for cryptococcosis.
  • To identify factors influencing prognosis and morbidity.

Main Methods:

  • Retrospective analysis of 27 cases of pulmonary and meningeal cryptococcosis.
  • Treatment involved combination therapy with amphotericin B and 5-fluorocytosine.
  • Surgical resection for incidental pulmonary cryptococcoma.

Main Results:

  • Combination therapy achieved good outcomes, with mortality avoided in responsive patients.
  • Early presentation and treatment were associated with better prognosis.
  • Visual impairment/blindness was the main morbidity, linked to intracranial hypertension.

Conclusions:

  • Symptomatic cryptococcosis requires combination therapy with amphotericin B and 5-fluorocytosine to a cumulative dose of 1.5g.
  • Asymptomatic pulmonary cryptococcoma can be managed with surgical resection.
  • Aggressive management of visual failure and papilledema is crucial for preventing permanent deficits.

Related Concept Videos